Latest Saniona News & Updates

See the latest news and media coverage for Saniona. We track all announcements, press releases, and industry mentions in real time, all in one place.

Saniona

Biotechnology company developing ion channel modulators

saniona.com

Headquarters: Glostrup, Denmark
Founded year: 2011
Company type: Private company
Number of employees: 10–60
Industry: Pharmaceuticals

Last updated Today

Latest news about Saniona

In short: Saniona advanced clinical epilepsy candidates and secured licensing deals with Jazz Pharmaceuticals and AstronauTx to drive growth.

Company announcements

August 10 Saniona

Saniona announces option exercise by AstronauTx for global rights

Saniona receives $5M in AstronauTx shares and up to $172M in potential milestone payments and royalties.

May 27 Saniona

Saniona announces decisions from the 2026 Annual General Meeting

The meeting approved the accounts, re-election of the board and rejection of two proposals due to shareholder opposition.

4 September 2025 Saniona

Saniona selects SAN2668 as clinical candidate for paediatric epilepsy

SAN2668 addresses sedation, cognitive impairment, and tolerance. The company advances three programs to Phase 2 and initiates preclinical development for Phase 1 in 2026.

25 August 2025 Saniona

Saniona hosts Q2 investor call

The call occurs on 28 August at 13:00 CET. Management presents results, updates, and hosts a Q&A session.

Media coverage

August 27 Yahoo Finance

Saniona AB (LTS:0RQJ) (Q2 2026) Earnings Call Highlights: Strategic Pipeline...

Saniona AB (LTS:0RQJ) narrows focus to SAN2668 and SAN2465, reporting a SEK58 million net loss while securing non-dilutive funding and advancing toward key clinical milestones.

August 18 BioStock

Saniona on the equity and milestone upside in the AstronauTx deal - Biostock

The aim of the collaboration is to discover treatments for Alzheimer's disease and other neurodegenerative conditions, pairing Saniona's IonBase platform with AstronauTx's expertise in sleep...

August 10 Affärsvärlden

Irregular lunch stock exchange – Medicover retreats

The Stockholm stock exchange is trading in an irregular trend at lunchtime on Monday.

August 9 FinanzNachrichten.de

Saniona AB: AstronauTx exercises option from Saniona to acquire worldwide rights to neurological disease program under research collaboration

Development candidate ATX0926 enters IND-enabling stage of development expanding AstronauTx's pipeline of therapies targeting sleep biologyRepresents the successful outcome of a multi-year scientific ...

Never miss news about Saniona

Track Saniona and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Saniona competitors & trending companies

Browse news for competitors to Saniona and other trending companies.